The useful question is not whether olive oil is “good for the brain” in a vague wellness sense. It is whether human studies can separate olive oil from the rest of the Mediterranean diet and show measurable changes in memory, attention, executive function, brain imaging or cognitive decline. Kanaan and colleagues’ 2026 systematic review in Foods is useful because it does exactly that: it narrows the question to adult studies where olive oil, its fatty-acid profile, or olive-derived bioactives were linked to validated cognitive outcomes.
Study overview
The paper is “Impact of Olive Oil Fatty Acids and Bioactive Compounds on Cognitive Function in Adults: A Systematic Review”, published in Foods in 2026 by Abdallah Kanaan and colleagues. It was conducted under PRISMA 2020 guidelines and registered with PROSPERO (CRD420251173429). The authors searched PubMed, Scopus and EBSCO, screened the first 200 Google Scholar records, and performed citation tracking. Searches covered English-language peer-reviewed studies from November 2015 to November 2025.
The funnel was tight. The team identified 270 records, removed 27 duplicates, screened 243 titles and abstracts, reviewed 8 full texts, and included only 6 studies: five randomized controlled trials and one prospective cohort. Total sample size across included studies was 433 adults if the n values reported in the review’s baseline table are summed, with individual studies ranging from 18 to 154 participants. Follow-up in randomized trials ranged from 12 weeks to 12 months.
Key findings: what the human data actually showed
This was not a meta-analysis. The authors explicitly avoided pooling results because the studies varied too much by population, intervention, comparator, dose and cognitive testing. That is the right call. A pooled number would have looked more impressive, but probably less honest.
| Study | Design | Exposure | Main signal |
|---|---|---|---|
| Mazza et al. 2018 | RCT, n = 110 adults ≥65 | Mediterranean diet + 20-30 g/day EVOO vs Mediterranean diet alone | Greater ADAS-Cog improvement with EVOO; p = 0.024 |
| Yoon et al. 2023 | Double-blind RCT, n = 72 adults aged 51-82 | 3 g hydroxytyrosol-rich desert olive tree pearls twice daily vs placebo | Attention improved; p < 0.05 |
| Marianetti et al. 2022 | Crossover RCT, n = 18 mild Alzheimer’s disease patients | Oleuropein + S-acetyl glutathione nutraceutical | Stabilization/improvement on MMSE, RAVLT, FAB and behavioural outcomes |
| Kaddoumi et al. 2022 | Blinded RCT, n = 25 adults with MCI | 30 mL/day high-polyphenol EVOO vs 30 mL/day refined olive oil | Reduced blood-brain-barrier permeability and improved connectivity/cognition signals |
| Tsolaki et al. 2020 | Double-blind prospective RCT, n = 54 adults with MCI | High-phenolic early-harvest EVOO vs moderate-phenolic EVOO vs Mediterranean-diet advice | High-phenolic EVOO showed the best cognitive improvement |
| Sakurai et al. 2021 | Prospective cohort, n = 154 adults ≥60 | Dietary fat/MUFA/oleic-acid intake assessment | Oleic acid intake associated with better MoCA and WMS delayed-recall scores |
Two findings are especially actionable. First, Mazza et al. tested a realistic food substitution: older adults following a Mediterranean diet either added 20-30 g/day EVOO or continued the Mediterranean diet alone. The EVOO arm improved more on ADAS-Cog, with p = 0.024. Second, Tsolaki et al. compared high-phenolic early-harvest EVOO with moderate-phenolic EVOO and Mediterranean-diet advice in adults with mild cognitive impairment; the high-phenolic arm produced the strongest cognitive signal. That matters because it suggests “olive oil” may not be the active category — phenolic-rich extra virgin olive oil may be.
The GRADE ratings keep the enthusiasm under control. The review rated the certainty of evidence as moderate for memory and attention, low for global cognition and executive function, and very low for blood-brain-barrier integrity, because that imaging endpoint depends mainly on one small randomized trial.
Mechanism: why EVOO could plausibly affect cognition
The biology is not magic and it is not just “antioxidants.” EVOO carries oleic acid, tocopherols, and a phenolic fraction that can include hydroxytyrosol, tyrosol, oleuropein derivatives, oleocanthal and oleacein. The review highlights several plausible pathways: lower oxidative stress, dampened neuroinflammation, improved vascular function, protection of blood-brain-barrier integrity, and changes in functional brain connectivity.
Those pathways fit the broader olive-oil literature. Vascular health and cognition are tightly linked: small-vessel injury, endothelial dysfunction and chronic inflammation all increase cognitive-risk pressure over time. Hydroxytyrosol and oleuropein are also credible candidates because they interact with oxidative and inflammatory signalling, while oleocanthal has been studied for anti-inflammatory activity and amyloid-related mechanisms. But the key word is plausible. Mechanism strengthens interpretation; it does not replace hard clinical outcomes.
Context: how this compares with previous research
This review lines up with the direction of PREDIMED-style findings: Mediterranean diet patterns enriched with EVOO tend to perform better than low-fat advice on several cardiovascular and cognitive-adjacent outcomes. It also agrees with newer mechanistic work showing that high-polyphenol EVOO can influence postprandial lipid handling, oxidative stress, endothelial biology and even small neuroimaging signals.
The tension is that the cognition evidence is smaller and messier than the heart-health evidence. Cardiovascular trials can use blood pressure, LDL oxidation, events or ambulatory monitoring. Cognition is harder: ADAS-Cog, MMSE, MoCA, delayed recall, executive-function batteries and imaging do not always move together. A 12-week attention signal in healthy adults is not the same as slower dementia progression. This review is strongest as a map of where the signal appears, not as final proof.
Practical takeaway
If you are choosing a daily fat for long-term brain health, the evidence supports a simple default: use fresh extra virgin olive oil as the main added fat, ideally within a Mediterranean-style pattern rich in vegetables, legumes, fish, nuts and minimally processed foods. The human studies include realistic doses such as 20-30 g/day and 30 mL/day, which is roughly two tablespoons.
The more interesting detail is quality. If cognitive benefit depends partly on phenolics, then bland refined olive oil and old, low-polyphenol EVOO are not equivalent to fresh high-phenolic oil. Choose recent-harvest EVOO, protect it from heat and light, and use it consistently rather than treating it like a supplement you remember twice a week.
Limitations
The review’s limitations are serious. Six included studies is a small evidence base. Several trials were tiny: the Alzheimer’s crossover study had 18 participants, and the blood-brain-barrier trial had 25. The interventions were not identical: some tested EVOO, some high-phenolic EVOO, some refined olive oil comparators, some oleuropein or hydroxytyrosol-rich products, and one cohort focused on oleic-acid intake. Risk of bias was not reassuring either: the baseline table rated several included RCTs as high risk of bias, while only the Tsolaki high-phenolic EVOO trial was listed as low risk.
There is also a publication-bias problem the authors could not formally test. With only six studies, no funnel plot or statistical reporting-bias test would mean much. Finally, the review did not provide a pooled effect size, so readers should not walk away with a single “EVOO improves cognition by X%” claim. That number does not exist yet.
Our take
This is a good evidence-mapping paper, not a game-changer. Its value is that it refuses to overstate the case. The pattern is encouraging: five RCTs and one cohort lean toward benefits in memory, attention, global cognition, blood-brain-barrier measures or related cognitive domains. But the clinical confidence is uneven, especially for dementia prevention.
My read: EVOO is already justified as a cardiometabolic default, and brain health is an additional reason to make it your main fat. The best version of the claim is modest but useful: regular, phenolic-rich EVOO fits the biology of cognitive protection and has early human support, but it is not a stand-alone treatment for cognitive decline. For a health-conscious person, that is still enough to change the shopping list.
Reference
Kanaan A, Abuzaid H, Papandreou C. Impact of Olive Oil Fatty Acids and Bioactive Compounds on Cognitive Function in Adults: A Systematic Review. Foods. 2026;15(10):1791. doi:10.3390/foods15101791. PMID: 42195994.